Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PGDS as modifiers of the PTEN pathway and methods of use

PGDS as modifiers of the PTEN pathway and methods of use

US Patent 8288119 · Granted Oct 16, 2012

Estimated economic value: $14,065,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cancer using combination therapies comprising GDC-6036 and GDC-00772025
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2023
RNAi constructs for inhibiting ASGR1 expression and methods of use thereof2020
CDK9 as modifier of the IGF pathway and methods of use2014
CDK9 as modifier of the IGF pathway and methods of use2014
EEF2K as modifiers of the PTEN/AKT pathway and methods of use2014
PLKS as modifiers of the beta catenin pathway and methods of use2014
PIK4CA as modifier of the Rac pathway and methods of use2013
Mylks as modifiers of branching morphogenesis and methods of use2012
C20ORF23 as modifier of the IGFR pathway and methods of use2011
ALDOs as modifiers of the IGF pathway and methods of use2011
PDEs as modifiers of the IGFR pathways and methods of use2011